Institutional investors purchased a net $1.7 million shares of SNSS during the quarter ended June 2017 and now own 49.99% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BALYASNY ASSET MANAGEMENT LP Bought 2.0 Million shares of Sunesis Pharmaceuticals I...
TAVISTOCK LIFE SCIENCES CO. (INV... Bought 500.0 Thousand shares of Sunesis Pharmaceuticals I...